• We set great store by research – even though AOP Orphan is not a large company. Top priority here is on securing the support and experience of patients.

    Dr. Christoph Klade

    Chief Scientific Officer

  • To provide patients with effective drugs COLLABORATION is the key for success- within and between pharmaceutical industry and academia

    Assoc. Prof. Dr. Kurt Krejcy

    Chief Medical Officer

  • As a company, we are small enough to be really close to our patients, yet we are large enough to be able to provide them high-quality, personalized customer care.

    Dr. Rudolf Widmann

    Chief Executive Officer Chairman of the Board

  • Our commitment does not stop at the company’s door. It is our guiding principle – wherever we go and whenever we’re needed.

    Dr. Georg Fischer

    Chief of Corporate Development

You are here:

  • Home
  • Research and Development

AOP Orphan Contact

AOP Orphan worldwide

Wilhelminenstraße 91/IIf
1160 Vienna, Austria
office(at)aoporphan.com

Research and Development


AOP Orphan is a research-oriented pharmaceutical company and invests a high amount of its yearly turnover in the Research and Development of drugs. AOP Orphan primarily focuses on rare diseases, otherwise referred to as orphan diseases. The European Union states that a disease can be classified as rare if only 5 out of 10,000 people are affected by it.

As a fully integrated pharmaceutical company, AOP Orphan's areas of activities cover the research, development, production, marketing and distribution of medication.

How does AOP Orphan research and develop?

AOP Orphan’s in-house research team covers all key aspects of product development including preclinical research, toxicology, pharmaceutical development, clinical development, regulatory affairs, quality management, pharmacovigilance and project management.

continue to How does AOP Orphan research and develop?

Development Phases

Before a drug is released for sale, it needs to be tested in clinical trials for tolerability, safety and efficacy. Such trials are subject to strict, internationally recognized guidelines and must be carried out using defined procedures.

continue to Development Phases

Research Areas

AOP Orphan is actively involved in a range of research projects focusing on rare diseases.

continue to Research Areas

Current Studies

The current focus of research activities is on myeloproliferative and cardiovascular diseases.

continue to Current Studies

Cooperation Agreements

AOP Orphan can draw on a global network of cooperation agreements which cover the areas of research, production and distribution in equal measure.

continue to Cooperation Agreements